The United States is an engine for healthcare innovation offering Swedish life science companies unparallelled opportunities to accelerate growth. But entering the market is only the beginning. Success requires a clear strategy, tactics and local knowledge.
Team Sweden’s Life Science Needs Analysis 2026 examines the opportunities that make the US so attractive and uncovers the practical realities of breaking into the US healthcare ecosystem, ranging from funding to regulatory pathways.
Download the report for first-hand insights into:
- Key priorities on the ground
- The most common barriers to achieving goals
- Where coordinated support matters most
